| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOCN | Common Stock | Options Exercise | $40,320 | +6,000 | +4.2% | $6.72* | 150,262 | 14 Aug 2023 | Direct | |
| transaction | DOCN | Common Stock | Sale | $213,060 | -6,000 | -4% | $35.51 | 144,262 | 14 Aug 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOCN | Stock Option (Right to buy) | Options Exercise | $0 | -6,000 | -1.7% | $0.000000 | 348,240 | 14 Aug 2023 | Common Stock | 6,000 | $6.72 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $35.20-$35.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | One fourth of the shares underlying this option vested and became exercisable on February 18, 2021, and the remaining shares underlying this option vest in 36 equal monthly installments beginning on March 18, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date. |